A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
This study aims to evaluate the acceptability, safety, and efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.
Eligibility criteria
Qualifiers
Adults ages 18+
Relatively frequent and recent (≥5 days within the past-month) active suicidal thoughts as assessed via SITBI-R.
Willing and able to provide at least one emergency contact (name, phone number, relation).
Owns an Android or iOS smartphone.
Disqualifiers
Recent (past 3-month) hypo/manic symptoms or homicidal ideation or lifetime psychosis spectrum diagnosis as assessed via MINI 7.0.2.
At any time in past week: ≥ 8/10 current intent to act on suicidal thoughts (0 ["not at all"] to 10 ["extremely strong"]); AND
At any time in past week: thought of a specific suicide plan (i.e, known method/means and/or location) with access to lethal means
Impaired vision (e.g., legal blindness), technological illiteracy, or intellectual disability that might impair ability to provide valid data and/or informed consent.
Trial design
Treatments tested in this trial
- Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S)
- Smartphone-delivered inactive Therapeutic Evaluative Conditioning
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Massachusetts General Hospital
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov